BioNTech : Fourth Quarter and Full Year 2022 Earnings Presentation

Financial Results & Corporate Update


4th Quarter and Full Year 2022


27.03.2023


This Slide Presentation Includes... | March 27, 2023

Related Keywords

United States ,Ryan Richardson ,Ugur Sahin ,Jens Holstein ,Centers For Disease ,Committee For Medicinal Products Human Use ,European Union ,European Commission ,European Medicines Agency ,Pfizer ,Financial Results ,Full Year ,Private Securities Litigation Reform Act ,Medicinal Products ,Human Use ,Product Characteristics ,Package Leaflet ,Emergency Use Authorization ,Coronavirus Disease ,Acute Allergic Reactions ,Disease Control ,Adverse Reactions ,Adverse Reactions Identified ,Post Authorization ,Chief Executive ,Chief Medical ,Chief Financial ,Chief Strategy ,Biontech Se Stock Exchange ,News ,Information ,Press Release ,Financial ,Results ,Corporate ,Ith ,Quarter ,End ,Bull ,Ear ,This ,Slide ,Resentation Bntx Us09075v1026 ,